by Jordana Choucair | Nov 18, 2021 | Mental Health
At the recent National Association of Medicaid Directors conference, Vikki Wachino, former CMS Director/Deputy Administrator of the Center for Medicaid and CHIP Services, shared her thoughts about the imperative to deliver for kids’ mental health. Vikki outlined...
by Jordana Choucair | Nov 18, 2021 | Life Sciences
The CMS extended the deadline for drugmakers to comply with the Trump-era regulation requiring them to calculate the “best price” for drugs under Medicaid’s drug rebate program using discounts they offer patients. The new final rule will officially...
by Jordana Choucair | Nov 18, 2021 | Life Sciences
AstraZeneca released new clinical trial results showing that its antibody treatment is highly effective at preventing COVID-19 in people who may not respond well to vaccines. According to the trial, patients given a single injection of the treatment were 83 percent...
by Jordana Choucair | Nov 18, 2021 | Life Sciences
Moderna submitted a revised request for the FDA to authorize booster doses of its COVID-19 vaccine for all adults. The FDA could grant Moderna and Pfizer clearance as early as this week. If the CDC also signs off, every adult who was fully vaccinated with the...
by Jordana Choucair | Nov 17, 2021 | Payers
New data from a Cigna subsidiary indicates that leveraging behavioral health treatment can result in a positive return on investment (ROI) for health plan sponsors. According to the research, behavioral health treatment in an outpatient setting leads to fewer...
by Jordana Choucair | Nov 17, 2021 | Payers
In a new Health Affairs blog post, CMS leadership outlined the agency’s agenda to expand coverage and access, improve equity, and encourage innovation. According to CMS Administrator Chiquita Brooks-LaSure and Center for Medicaid and Children’s Health Insurance...
Recent Comments